- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
|“Hisashi Ietsugu, President and CEO of Sysmex Corporation, and Paul Walker, Managing Director of Malvern Instruments, exchanged gifts during a celebration to mark the extension of Malvern’s direct operations in Japan.”|
Malvern Instruments has marked the extension of its direct operations in Japan with a celebration held on 1 October 2010 at the offices of Malvern Instruments Japan in Kobe.
Malvern Instruments Japan was established in February 2003 to manage Malvern's process business in the region. The newly expanded organisation is now set to deliver direct sales, technical and applications support across the entire range of the company's particle characterization systems.
This follows the conclusion of an agreement with Sysmex Corporation, who previously distributed Malvern's laboratory-based particle characterization systems in Japan, to transfer responsibility directly to Malvern. The two companies have also signed a new exclusive distribution agreement for the Sysmex FPIA particle characterization instrument, which will make Malvern the worldwide distributor including Japan.
Guests at the celebratory lunch were addressed by both Paul Walker, Managing Director of Malvern Instruments, and Hisashi Ietsugu, President and CEO of Sysmex Corporation, as well as Jim Fatkin, Malvern's Regional Manager for Asia.
Paul Walker thanked and paid tribute to the Sysmex teams, with whom Malvern has worked since 1998 and looked forward to building on the sound base of business that Sysmex has developed for Malvern's particle characterization systems in Japan.
"With the continued growth and diversification of the Malvern Instruments product range, now is the right time for us to extend our direct operation in Japan and to manage our particle characterization business through a single organization, as we do elsewhere," said Mr Walker. "I am delighted that we have also concluded a new distribution agreement for the Sysmex FPIA systems worldwide and that Malvern and Sysmex will continue to collaborate in developing particle characterization systems for the bioscience community."
Hisashi Ietsugu, President and CEO of Sysmex Corporation said: "The transfer of the Malvern and Sysmex industrial particle characterization business to Malvern Japan is a logical step in the development of our longstanding and successful relationship, in order to exploit synergies between products and markets. At the same time we are happy to have concluded a distribution agreement with Malvern for the Sysmex FPIA instrument, both inside and outside Japan, which we expect will enable us to further build on our success. While we will continue to collaborate in the industrial particle characterization area, we hope that opportunities will arise for the joint development of exciting new products in the bioscience field."
For further information about Malvern Instruments Japan please visit: www.malvern.jp
Malvern and Malvern Instruments are registered trademarks of Malvern Instruments Ltd
About Malvern Instruments
Malvern Instruments is a market leader in measuring performance controlling material properties. These include particle size, particle shape, zeta potential, molecular weight, size and conformation, rheological properties and chemical distribution. Malvern delivers the systems, support and expertise that ensure the analytical integrity and productivity needed to drive research, development and manufacturing.
Malvern's measurement solutions for scientists, technologists and engineers advance continually through customer collaboration. Complementary materials characterization systems deliver inter-related measurements that reflect the complexities of particulates and disperse systems, nanomaterials and macromolecules. Combining intelligently implemented technologies with in-depth industry applications knowledge and support, Malvern provides customers with the competitive advantage they demand.
Headquartered in Malvern, UK, Malvern Instruments has subsidiary organizations in all major European markets, North America, China, Korea and Japan, a joint venture in India, a global distributor network and applications laboratories around the world.
About Sysmex Corporation
Sysmex Corporation is a world leader in clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. Serving customers for more than 40 years, Sysmex focuses on technological leadership in diagnostic science and information tools that make a difference in the health of people worldwide. The company is also exploring emerging opportunities in the life science field. Its R&D efforts focus on the development of high-value-added testing and diagnostic technologies that are innovative, original and optimize individual health. Sysmex also seeks to leverage its state-of-the-art technologies for gene and protein analysis. The company, headquartered in Kobe, Japan, has subsidiaries in North America, Latin America, Europe, China and Asia Pacific and employs more than 4,000 employees worldwide. Sysmex Corporation is listed in the top tier of the Tokyo Stock Exchange. For more information about Sysmex Corporation and its affiliate companies, please visit www.sysmex.co.jp/en/
For more information, please click here
For press information, please contact:
Great North Road
Tel: +44 (0)1480 479280
Fax: +44 (0)1480 470343
Malvern Instruments Inc.
117 Flanders Road
Tel: +1 508 768 6400
Fax: +1 508 768 6403
Please send sales enquiries to:
Malvern Instruments Ltd
Enigma Business Park
Tel: +44 (0) 1684 892456
Fax: +44 (0) 1684 892789
Copyright © Malvern InstrumentsIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016